NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

表纸
市场调查报告书

临床决策支援系统的全球市场:成长,趋势,及预测(2019年~2024年)

Clinical Decision Support Systems Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

出版商 Mordor Intelligence Pvt Ltd 商品编码 391415
出版日期 内容资讯 英文 115 Pages
商品交期: 2-3个工作天内
价格
临床决策支援系统的全球市场:成长,趋势,及预测(2019年~2024年) Clinical Decision Support Systems Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
出版日期: 2021年03月01日内容资讯: 英文 115 Pages
简介

全球临床决策支援系统市场成长要素,有减少人为错误的必要性,削减医疗费的要求高涨,改善照护品质的必要性,慢性疾病人口的增加,新兴经济国的采用率的增加等。

本报告提供全球临床决策支援系统市场的相关调查,市场机会和趋势,成长及阻碍因素,各模式、传送、零组件、产品、用途、地区的市场分析,竞争情形,主要企业的简介等资讯

目录

第1章 简介

  • 调查成果
  • 调查的假设
  • 调查范围

第2章 调查方法

第3章 摘要整理

第4章 市场动态

  • 市场概况
  • 成长要素
  • 阻碍因素
  • 波特的五力分析
    • 新加入厂商的威胁
    • 买主/消费者谈判力
    • 供应商谈判力
    • 替代产品的威胁
    • 产业内的竞争

第5章 市场区隔

  • 各模式
    • 知识为基础的CDSS
    • 非知识为基础的CDSS
  • 各传送模式
    • 云端基础
    • 内部部署
  • 各零件
    • 硬体设备
    • 软体
    • 服务
  • 各产品
    • 整合系统
    • 独立系统
    • 标准为基础
    • 服务模型化
    • 其他
  • 各用途
    • 医疗诊断
    • 警报、提醒
    • 处方决策的支援
    • 资讯搜寻
    • 影像识别、解释
    • 治疗的批评、计划
    • 其他
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 中东、非洲地区
    • 南美

第6章 竞争情形

  • 企业简介
    • Cerner Corporation
    • EPIC
    • IBM
    • Mckesson Corporation
    • Meditech
    • Koninklijke Philips N.V.
    • Siemens Healthcare

第7章 市场机会及未来趋势

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: 50913

The Clinical Decision Support Systems Market was valued at approximately USD 1,450 million in 2020 and it is expected to reach USD 2,490 million by 2026, registering a CAGR of nearly 9.4% during the forecast period (2021-2026).

Amid the COVID-19 pandemic, the health systems of countries are majorly dependent on online services. Through video calls, patients are getting appointments with doctors, which is helping in treating and monitoring the diseases, which is likely to propel the clinical decision support systems market.

According to the World Ageing 2019 report, it was estimated that there were 703 million persons aged 65 years or over in the world in 2019. This group of the population mainly suffers from a lot of chronic diseases and needs regular health checks and treatments for the prevention of diseases. Based on the current situation across the world, there might be a lot of people, such as the elderly population and pregnant women, who may in need of health checks, but due to the COVID-19 outbreak across the world, the hospitals and clinics unable to provide services. But several countries are increasingly providing online services, which is boosting the market.

Moreover, the healthcare facilities, such as hospitals, diagnostic centers, and clinics, are showing interest in clinical decision support systems in minimizing medication prescription errors, adverse drug events monitoring, and other medical errors.

The rising demand for reducing healthcare expenditure, need for improvement in the quality of care, and technological advancement in Healthcare IT in hospitals are the major factors that are likely to boost the growth of the clinical decision support systems (CDSS) market.

Furthermore, according to the Organization for Economic Co-operation and Development (OECD) survey report, in 2018, average per capita health expenditure was about USD 7,317 in Switzerland, USD 6,187 in Norway, and USD 5,005 in Australia, respectively. Due to high healthcare expenditure across the world, the rising demand to reduce healthcare expenditure shows a positive impact on the market.

According to a study report by Elena Bellodi et. al. published in the BMC Medical Informatics and Decision Making 2017, the implementation of a clinical decision support system (CDSS) can have a positive impact on health care costs. Furthermore, the experience of using a clinical decision support system (CDSS) can also result in good practice to be implemented by other health care organizations as per the study conducted in Italy.

However, lack of trust in the systems, as CDSS are in the initial stages of development, lack of skilled labour, and suggestions from CDSS for unnecessary diagnostic testing hinders the market growth.

Key Market Trends

Cloud-based Segment is Expected to Hold a Major Market Share in the Clinical Decision Support Systems Market

The increasing healthcare expenditure and adoption of cloud computing is the major driver for the expansion of the cloud-based segment of the market. According to a survey by RightScale, nearly 95% of organizations run cloud-based applications. The hardware of electronic medical record (EMR) systems offered by different vendors is different. Hence, developing a standard CDSS software, which can run on multiple EMR systems, is a major challenge.

Furthermore, local knowledge management of CDSS may require extensive processing power and storage capacity, which can result in high operating costs. In contrast, cloud-based applications are operated in remote servers, and executing them does not require a large amount of computational power or large storage space in the user's device.

Cloud-based applications do not depend on web browsers, which makes them inherently safer than web-based applications. In a cloud-based clinical decision support system, processing units are hosted on remote servers, which can be located in multiple data centers across the world, making them less vulnerable to cyberattacks. The increasing availability of cloud technology, owing to their benefit, is expected to drive the usage of cloud-based CDSS, over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

The clinical decision support systems (CDSS) market in North America is driven due to the rise in the technological advancement in the CDSS, higher awareness rate among patients, and rising investments in healthcare IT solutions in the region are expected to boost the growth of the market during the forecast period.

As per the Centers for Disease Control and Prevention (CDC) 2019, six in ten Americans have at least one chronic disease, like heart disease and stroke, cancer, or diabetes. These chronic diseases are the leading causes of death and disability in the United States, and they are also a leading driver of health care costs. Moreover, according to the Organization for Economic Co-operation and Development (OECD) survey report, in 2019, the average per capita health expenditure in the United States was about USD 11,072.

In 2016, the Agency for Healthcare Research and Quality (AHRQ) launched a new initiative to disseminate and implement the findings of patient-centered outcomes research (PCOR) through clinical decision support (CDS). The two major goals of the initiative were to accelerate the movement of evidence into practice through CDS and to make CDS more shareable, standards-based, and publicly available. Such research efforts help engage patients, clinicians, provider organizations, and information technology professionals, to improve decision making in healthcare with the help of CDSS. These initiatives will fuel the growth of the CDSS market, over the forecast period, in North America.

Competitive Landscape

The Clinical Decision Support Systems Market has the presence of well-diversified international, regional, and local players. However, some big international players dominate the market owing to their brand image and market reach The studied market is consolidated competitive. The market players are continuously focusing on acquisitions, mergers, provision of customized solutions, and expansion in the untapped commercial markets. Moreover, companies are also investing huge amounts on developing new products and platforms, with enhanced and improved features, as a part of the commercialization strategy.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Technological Advancement in Healthcare IT in hospitals
    • 4.2.2 Rising Demand to Reduce Healthcare Expenditure
    • 4.2.3 Need for Improvement in Quality of Care and Reducing Human Errors
  • 4.3 Market Restraints
    • 4.3.1 Privacy and Data Security Concerns Related to Cloud-Based CDSS
    • 4.3.2 Lack of Skilled Professionals
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Model
    • 5.1.1 Knowledge-based CDSS
    • 5.1.2 Non-knowledge CDSS
  • 5.2 By Mode of Delivery
    • 5.2.1 Cloud-based
    • 5.2.2 On-premise
  • 5.3 By Component
    • 5.3.1 Hardware
    • 5.3.2 Software
    • 5.3.3 Services
  • 5.4 By Product
    • 5.4.1 Integrated CDSS
    • 5.4.2 Standalone CDSS
  • 5.5 By Application
    • 5.5.1 Medical Diagnosis
    • 5.5.2 Alerts and Reminders
    • 5.5.3 Prescription Decision Support
    • 5.5.4 Information Retrieval
    • 5.5.5 Other Applications
  • 5.6 Geography
    • 5.6.1 North America
      • 5.6.1.1 United States
      • 5.6.1.2 Canada
      • 5.6.1.3 Mexico
    • 5.6.2 Europe
      • 5.6.2.1 Germany
      • 5.6.2.2 United Kingdom
      • 5.6.2.3 France
      • 5.6.2.4 Italy
      • 5.6.2.5 Spain
      • 5.6.2.6 Rest of Europe
    • 5.6.3 Asia-Pacific
      • 5.6.3.1 China
      • 5.6.3.2 Japan
      • 5.6.3.3 India
      • 5.6.3.4 Australia
      • 5.6.3.5 South Korea
      • 5.6.3.6 Rest of Asia-Pacific
    • 5.6.4 Middle East and Africa
      • 5.6.4.1 GCC
      • 5.6.4.2 South Africa
      • 5.6.4.3 Rest of Middle East and Africa
    • 5.6.5 South America
      • 5.6.5.1 Brazil
      • 5.6.5.2 Argentina
      • 5.6.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Cerner Corporation
    • 6.1.2 EPIC
    • 6.1.3 IBM
    • 6.1.4 Change Healthcare
    • 6.1.5 Meditech
    • 6.1.6 Koninklijke Philips NV
    • 6.1.7 Siemens Healthcare
    • 6.1.8 Allscripts Healthcare Solutions Inc.
    • 6.1.9 Wolters Kluwer Health
    • 6.1.10 Mckesson Corporation
    • 6.1.11 Zynx Health
    • 6.1.12 Elsevier B.V
    • 6.1.13 NextGen Healthcare, Inc.
    • 6.1.14 Agfa-Gevaert Group
    • 6.1.15 Athenahealth, Inc.
    • 6.1.16 VisualDx

7 MARKET OPPORTUNITIES AND FUTURE TRENDS